化合物Finerenone T21395
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
1 mL | 1050477-31-0 | ¥821.00 | 询底价 |
1 mg | 1050477-31-0 | ¥347.00 | 询底价 |
5 mg | 1050477-31-0 | ¥722.00 | 询底价 |
500 mg | 1050477-31-0 | ¥9,790.00 | 询底价 |
50 mg | 1050477-31-0 | ¥3,697.00 | 询底价 |
200 mg | 1050477-31-0 | ¥6,520.00 | 询底价 |
10 mg | 1050477-31-0 | ¥1,141.00 | 询底价 |
25 mg | 1050477-31-0 | ¥2,312.00 | 询底价 |
100 mg | 1050477-31-0 | ¥4,570.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Finerenone
描述: Finerenone (BAY-948862) 是一种选择性、具有口服活性的、非甾体类盐皮质激素受体拮抗剂 (IC50=18 nM)。与糖皮质激素受体、雄激素受体和孕酮受体相比,它表现出良好的选择性 (>500-fold)。它在心肾疾病研究中具有潜在的应用前景,如 2 型糖尿病和慢性肾脏疾病。
存储条件: keep away from direct sunlightPowder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 60 mg/ml (158.55 mM)
H2O : Insoluble
关键字: inhibit | cardiorenal | systolic | disease | pressure | diabetes | chronic | type | Finerenone | Inhibitor | kidney | Mineralocorticoid Receptor | oral | nonsteroidal | blood
相关产品: GSK9027 | Vamorolone | Fludrocortisone acetate | Dexamethasone | Hydrocortisone | Halcinonide | Cortisone | Meprednisone | Medroxyprogesterone Acetate | Prednisone acetate
相关库: Drug Repurposing Compound Library | Glycometabolism Compound Library | Anti-Cancer Compound Library | Anti-Cancer Drug Library | Inhibitor Library | Anti-Cancer Clinical Compound Library | Anti-Cancer Approved Drug Library | Highly Selective Inhibitor Library | EMA Approved Drug Library | Orally Active Compound Library
化合物Finerenone T21395信息由TargetMol中国为您提供,如您想了解更多关于化合物Finerenone T21395报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途